ARCHIVES

Also in this 8-page issue: John Montgomery, a founder of BioCryst Pharmaceuticals and a former member of the President’s Cancer Panel, dead.

This article is from The Cancer Letter archive.

Vol. 30 No. 27 | July 2, 2004

Download PDF Visit The Full Archive

Related Articles

Recommendation By Patients; report Of Protocol Committee

August 9, 1996

Race And Cancer: “It Would Be Wrong To Design Studies Based On Assumptions That Races Are Biologically Different,” Klausner Says

June 19, 1998

Adding Topotecan To Standard Treatment Doesn’t Improve Progression-Free Survival

October 29, 2010

In Brief: Peagler Heads AACE, Myers Is Presidents Elect; Bottiglieri Retires, Fink To Replace Him At ACS

January 6, 1984

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

NCAB Subcommittee Urges New Centers Categories, Recognition Of More New Comprehensive Centers

March 28, 1975